To identify potential therapeutic agents targeting the 14 key genes (PFKM, PKLR, FBP2, AGRN, ARTN, AURKA, CXCR4, DEPDC1, MERTK, PLOD2, SDC1, TPBG, VCAN, and PGP) implicated in IPF, we used the DGIdb. The gene discussed is PLOD2; the disease is idiopathic pulmonary fibrosis.